The Biomarker Exploratory Study in Prospective Multicenter Observational Study of Atezolizumab Combination Therapy in Lung Cancer (J-TAIL-2)

NCT04818983 · clinicaltrials.gov ↗

COMPLETED

Status

470

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-small Cell Lung Cancer
Extensive Disease Small Cell Lung Cancer

Sponsor

Chugai Pharmaceutical

Collaborators

[object Object]